Literature DB >> 51502

Inhibition of 4,alpha-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chloropromazine, haloperidol, clozapine and thioridazine.

J Buus Lassen.   

Abstract

The effect of H 77/77 (5 mg/kg s.c.) on motility of rats kept in a familiar cage was investigated. H 77/77 produced hypermotility, which was reduced by oral pretreatment with chlorpromazine, haloperidol, clozapine and thioridazine. The 4 neuroleptics were administered acutely and for a 14 day period. H 77/77 was given 30 min after the single or last dose of neuroleptc (chronic treatment) condition. After both single and repeated administration the neuroleptics showed H 77/77-antagonism in doses ranging from 0.1-2.0 mg/kg. The effect on H 77/77 activity did not change significantly after repeated treatment. Clozapine and thioridazine, which clinically produce only minor extrapyramidal side effects, exert a weak effect or none at all in tests commonly used for neuroleptic activity. These 2 neuroleptics were potent H 77/77-antagonists. Inhibition of H 77/77-hypermotility may possibly be used as a test for neuroleptics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51502     DOI: 10.1007/bf00437610

Source DB:  PubMed          Journal:  Psychopharmacologia


  37 in total

1.  ADRENERGIC MECHANISMS AND AMPHETAMINE INDUCED ABNORMAL BEHAVIOUR.

Authors:  A RANDRUP; I MUNKVAD; P UDSEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Authors:  P A JANSSEN; C J NIEMEGEERS; K H SCHELLEKENS
Journal:  Arzneimittelforschung       Date:  1965-02

3.  A comparison of the therapeutic and toxic effects of thioridazine and chlorpromazine in chronic schizophrenic patients.

Authors:  F N WALDROP; R H ROBERTSON; A VOURLEKIS
Journal:  Compr Psychiatry       Date:  1961-04       Impact factor: 3.735

4.  Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine.

Authors:  H Nybäck
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

5.  Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.

Authors:  J B Lassen
Journal:  Psychopharmacologia       Date:  1974

6.  Pharmacology of neuroleptics upon repeated administration.

Authors:  I Moller Nielsen; B Fjalland; V Pedersen; M Nymark
Journal:  Psychopharmacologia       Date:  1974-01-11

7.  Amphetamine induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open-field test with rats.

Authors:  E Schiorring
Journal:  Behaviour       Date:  1971       Impact factor: 1.991

8.  Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat.

Authors:  H R Bürki; W Ruch; H Asper; M Baggiolini; G Stille
Journal:  Eur J Pharmacol       Date:  1974-07       Impact factor: 4.432

9.  [Pharmacological and neurochemical effects of clozapine (Leponex): new aspects in the drug therapy of schizophrenia].

Authors:  H R Bürki; W Ruch; H Asper; M Baggiolini; G Stille
Journal:  Schweiz Med Wochenschr       Date:  1973-12-01

10.  Effects of clozapine on cerebral catecholaminergic neurone systems.

Authors:  G Bartholini; W Haefely; M Jalfre; H H Keller; A Pletscher
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

View more
  2 in total

1.  Evidence for a dopaminergic dominance in the 4,alpha-dimethyl-m-tyramine-induced hypermotility in mice.

Authors:  C Rüdeberg
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

2.  Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.

Authors:  D J Heal; A R Green; D J Boullin; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.